Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases

Brain, Behavior, and Immunity

Volumn 24, Issue 7, 2010, Pages 1069-1073

  Morer, Astrid ^a,b   Chae, Wookjin ^a   Henegariu, Octavian ^a   Bothwell, Alfred L M ^a   Leckman, James F ^a   Kawikova, Ivana ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

IL 2; MCP 1; Post mortem specimen of basal ganglia; PTPR N IA 2; Tourette's syndrome

Indexed keywords

INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN TYROSINE PHOSPHATASE RECEPTOR N; PROTEIN TYROSINE PHOSPHATASE RECEPTOR U; RECEPTOR PROTEIN; RECOVERIN; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; CASE REPORT; CONTROLLED STUDY; GENE EXPRESSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, CD45; AUTOPSY; BASAL GANGLIA; CHEMOKINE CCL2; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-2; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; RECOVERIN; RNA; TOURETTE SYNDROME;

EID: 77956406089     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.02.007     Document Type: Article

References (28)

1. Banisadr G., Gosselin R.D., Mechighel P., Rostene W., Kitabgi P., Melik Parsadaniantz S. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 2005, 492:178-192.
2. Bronze M.S., Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 1993, 151:2820-2828.
3. Bustin S.A., Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin. Sci. (Lond.) 2005, 109:365-379.
4. Chintawar S., Cayrol R., Antel J., Pandolfo M., Prat A. Blood-brain barrier promotes differentiation of human fetal neural precursor cells. Stem Cells 2009, 27:838-846.
5. Church A.J., Dale R.C., Lees A.J., Giovannoni G., Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J. Neurol. Neurosurg. Psychiatry 2003, 74:602-607.
6. Eisenbarth G.S., Jeffrey J. The natural history of type 1A diabetes. Arq. Bras. Endocrinol. Metabol. 2008, 52:146-155.
7. Frey K.A., Albin R.L. Neuroimaging of Tourette syndrome. J. Child Neurol. 2006, 21:672-677.
8. Giedd J.N., Rapoport J.L., Leonard H.L., Richter D., Swedo S.E. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35:913-915.
9. Gordon R.J., McGregor A.L., Connor B. Chemokines direct neural progenitor cell migration following striatal cell loss. Mol. Cell. Neurosci. 2009, 41:219-232.
10. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J. Neuroimmunol. 2000, 111:195-202.
11. Hoekstra P.J., Manson W.L., Steenhuis M.P., Kallenberg C.G., Minderaa R.B. Association of common cold with exacerbations in pediatric but not adult patients with tic disorder: a prospective longitudinal study. J. Child Adolesc. Psychopharmacol. 2005, 15:285-292.
12. Hong J.J., Loiselle C.R., Yoon D.Y., Lee O., Becker K.G., Singer H.S. Microarray analysis in Tourette syndrome postmortem putamen. J. Neurol. Sci. 2004, 225:57-64.
13. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13307-13312.
14. Kataoka Y., Kalanithi P.S., Grantz H., Schwartz M.L., Saper C., Leckman J.F., Vaccarino F.M. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol. 2009, 518:277-291.
15. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993, 92:39-43.
16. Lawrence D.M., Seth P., Durham L., Diaz F., Boursiquot R., Ransohoff R.M., Major E.O. Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells. Glia 2006, 53:81-91.
17. Leckman J.F. Tourette's syndrome. Lancet 2002, 360:1577-1586.
18. Lombroso P.J., Scahill L. Tourette syndrome and obsessive-compulsive disorder. Brain Dev. 2008, 30:231-237.
19. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
20. Morer A., Lazaro L., Sabater L., Massana J., Castro J., Graus F. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J. Psychiatr. Res. 2008, 42:64-68.
21. Muller N., Riedel M., Blendinger C., Oberle K., Jacobs E., Abele-Horn M. Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res. 2004, 129:119-125.
22. Nishimura T., Harashima S., Yafang H., Notkins A.L. IA-2 modulates dopamine secretion in PC12 cells. Mol. Cell. Endocrinol. 2009, 315:81-86.
23. Nishimura T., Kubosaki A., Ito Y., Notkins A.L. Disturbances in the secretion of neurotransmitters in IA-2/IA-2beta null mice: changes in behavior, learning and lifespan. Neuroscience 2009, 159:427-437.
24. Rao D.A., Pober J.S. Endothelial injury, alarmins, and allograft rejection. Crit. Rev. Immunol. 2008, 28:229-248.
25. Rizzo R., Gulisano M., Pavone P., Fogliani F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J. Child Neurol. 2006, 21:747-753.
26. Semple, B.D., Bye, N., Rancan, M., Ziebell, J.M., Morganti-Kossmann, M.C., 2009. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J. Cereb. Blood Flow Metab. doi:10.1038/jcbfm.2009.262.
27. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 1998, 155:264-271.
28. Thompson W.L., Karpus W.J., Van Eldik L.J. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J. Neuroinflammation 2008, 5:35.